The statement “90% of prostate cancer is fine” is wrong, it is a malignant tumor, the prognosis is related to the clinical stage, disease, etc. One study said that its 5-year overall survival rate is 78.9%.
Prostate cancer is one of the common malignant tumors in older men, and according to 2018 statistics, it is the most common malignant tumor in Western men, ranking second in tumor-related deaths. The incidence of prostate cancer in China is lower than that in western countries, but it has been on the rise in the last decade or so, and has become one of the most important diseases threatening men’s health in China.
The prognosis of prostate cancer is closely related to the age at first diagnosis, PSA level at first diagnosis, Gleason total score and distant metastasis of the cancer, etc. According to some studies, the 1-, 3- and 5-year overall survival rates of patients with prostate cancer are 96.0%, 87.3% and 78.9%, respectively.
If prostate cancer is suspected or diagnosed, it is recommended to go to a regular hospital for a comprehensive assessment of the condition and follow the doctor’s instructions for treatment to avoid delays.